Related references
Note: Only part of the references are listed.The speciation of vanadium in human serum
Tamas Jakusch et al.
COORDINATION CHEMISTRY REVIEWS (2011)
Interaction of VO2+ Ion and Some Insulin-Enhancing Compounds with Immunoglobulin G
Daniele Sanna et al.
INORGANIC CHEMISTRY (2011)
Is the Spin-Orbit Coupling Important in the Prediction of the 51V Hyperfine Coupling Constants of VIVO2+ Species? ORCA Versus Gaussian Performance and Biological Applications
Giovanni Micera et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Implications of oxidovanadium(IV) binding to actin
Susana Ramos et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components
J. Costa Pessoa et al.
CURRENT MEDICINAL CHEMISTRY (2010)
New Developments in the Comprehension of the Biotransformation and Transport of Insulin-Enhancing Vanadium Compounds in the Blood Serum
Daniele Sanna et al.
INORGANIC CHEMISTRY (2010)
A quantitative study of the biotransformation of insulin-enhancing VO2+ compounds
Daniele Sanna et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Decavanadate interactions with actin: cysteine oxidation and vanadyl formation
Susana Ramos et al.
DALTON TRANSACTIONS (2009)
On the prediction of V-51 hyperfine coupling constants in (VO)-O-IV complexes through DFT methods
Giovanni Micera et al.
DALTON TRANSACTIONS (2009)
Biospeciation of various antidiabetic (VO)-O-IV compounds in serum
Tamas Jakusch et al.
DALTON TRANSACTIONS (2009)
On the Transport of Vanadium in Blood Serum
Daniele Sanna et al.
INORGANIC CHEMISTRY (2009)
Interaction of VO2+ ion with human serum transferrin and albumin
Daniele Sanna et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Vanadium treatment of type 2 diabetes: A view to the future
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Current state for the development of metallopharmaceutics and anti-diabetic metal complexes
Hiromu Sakurai et al.
CHEMICAL SOCIETY REVIEWS (2008)
Biospeciation of antidiabetic VO(IV) complexes
Tamas Kiss et al.
COORDINATION CHEMISTRY REVIEWS (2008)
Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications
Elzbieta Lodyga-Chruscinska et al.
DALTON TRANSACTIONS (2008)
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): Transport and biotransformation of insulin-enhancing vanadium pharmaceuticals
BD Liboiron et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds
DC Crans et al.
CHEMICAL REVIEWS (2004)
Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes
Y Shechter et al.
COORDINATION CHEMISTRY REVIEWS (2003)
Coordination chemistry of vanadium in metallopharmaceutical candidate compounds
KH Thompson et al.
COORDINATION CHEMISTRY REVIEWS (2001)
Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV)
GR Willsky et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2001)
Speciation and NMR relaxation studies of VO(IV) complexes with several O-donor containing ligands:: oxalate, malonate, maltolate and kojate
P Buglyó et al.
INORGANICA CHIMICA ACTA (2000)
Design of vanadium compounds as insulin enhancing agents
KH Thompson et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2000)
Share Paper
